• Luciano Santana-Cabrera, Juan Ocampo-Pérez, Cristina Rodríguez-Escot, Marcos Granados-Rodríguez, and Hugo Rodríguez-Pérez.
• a Intensive Care Department , Universitary Hospital Insular in Gran Canaria, Las Palmas de Gran Canaria, España , Canary Islands , Spain.
• Br J Neurosurg. 2016 Jan 1; 30 (2): 274-6.

ObjectiveThe aim of this study was to evaluate the safety and outcomes of decompressive craniectomy (DC) after intravenous tissue plasminogen activator (IV tPA) administration for malignant cerebral infarction.MethodsWe retrospectively reviewed patients who underwent DC for malignant cerebral infarction. We compared fourteen patients who underwent DC after IV tPA administration with another nine patients who underwent DC without prior IV tPA administration.ResultsTwenty-three patients underwent DC for malignant hemispheric cerebral infarction in our hospital for five years. Fibrinolysis was performed prior to the DC in fourteen patients (60,9%). The patients characteristics did not differ between the DC patients with and without prior IV tPA administration. The complications that developed after DC were similar in both groups: in patients who underwent DC after IV tPA administration, 9 (64.3%) developed haemorrhagic transformation and 6 (42.9%) developed hydrocephalus. The functional outcome, as the 6-month GOS, was similar in both groups (p = 0.762). ICU mortality (p = 0.329) and hospital mortality after ICU (p= 0.634) were also similar between the two groups.ConclusionAlthough the main limitation is that the number of patients in our serie was small, which reduced the statistical power, our study suggest that DC after failure of IV tPA administration for malignant cerebral infarction is safe and did not cause an excess of complications arising from the use of fibrinolytic.

25 keywords...

hide…